Bicycle Therapeutics plc - stock earnings
BCYC Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | -0.62 / -1.27 | - | 19.5 million / 6.2 million | - |
BCYC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -49.1 million USD | 5.3 million USD |
| 2023Q3 | -49.9 million USD | 5.4 million USD |
| 2023Q2 | -42.6 million USD | 11.4 million USD |
| 2023Q1 | -39.1 million USD | 4.9 million USD |
| 2022Q4 | -30.0 million USD | 3.2 million USD |
| 2022Q3 | -28.3 million USD | 3.0 million USD |
| 2022Q2 | -26.8 million USD | 4.4 million USD |
| 2022Q1 | -27.6 million USD | 3.9 million USD |
| 2021Q4 | -18.0 million USD | 3.8 million USD |
| 2021Q3 | -14.7 million USD | 4.3 million USD |
| 2021Q2 | -17.9 million USD | 1.8 million USD |
| 2021Q1 | -16.2 million USD | 1.8 million USD |
| 2020Q4 | -17.4 million USD | 3.8 million USD |
| 2020Q3 | -10.1 million USD | 3.8 million USD |
| 2020Q2 | -12.1 million USD | 1.6 million USD |
| 2020Q1 | -11.3 million USD | 1.1 million USD |
| 2019Q4 | -4.4 million USD | 5.3 million USD |
| 2019Q3 | -9.5 million USD | 614000 USD |
| 2019Q2 | -10.2 million USD | 1.5 million USD |
| 2019Q1 | -6.5 million USD | 6.4 million USD |
| 2018Q4 | -6.6 million USD | 1.1 million USD |
| 2018Q3 | -7.7 million USD | 1.6 million USD |
| 2018Q2 | -5.0 million USD | 1.7 million USD |
| 2018Q1 | -2.5 million USD | 2.8 million USD |
| 2017Q4 | -5.8 million USD | 655000 USD |
BCYC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -180.7 million USD | 27.0 million USD |
| 2022 | -112.7 million USD | 14.5 million USD |
| 2021 | -66.8 million USD | 11.7 million USD |
| 2020 | -51.0 million USD | 10.4 million USD |
| 2019 | -30.6 million USD | 13.8 million USD |
| 2018 | -21.8 million USD | 7.1 million USD |
| 2017 | -16.3 million USD | 2.1 million USD |
| 2016 | -13.5 million USD | ? USD |
BCYC
Price: $24.69
52 week price:
Earnings Per Share: -5.08 USD
P/E Ratio: -3.47
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 365200
Market Capitalization: 862.9 million